Literature DB >> 986946

Differential attenuation of some effects of haloperidol in rats given scopolamine.

P Setler, H Sarau, G McKenzie.   

Abstract

In a series of pharmacological tests the ability of 0.6 mg/kg of the anticholinergic scopolamine to decrease the effectiveness of the neuroleptic heloperidol varied widely. Most severely attenuated was production of catalepsy followed in order of decreasing interference by inhibition of amphetamine-induced rotation, inhibition of amphetamine- or apomorphine-induced stereotyped behavior, inhibition of conditioned avoidance responding and lastly attenuation of the haloperidol-induced increase in striatal HVA. By use of such a relatively low dose of scopolamine the behavioral effects of heloperidol were dissociated from effects on dopamine turnover in the striatum. If behavioral tests in animals can be related to the clinical effects of neuroleptic drugs, those effects of haloperidol severely reduced by scopolamine may be related to extrapyramidal effects.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 986946     DOI: 10.1016/0014-2999(76)90119-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency.

Authors:  T Ljungberg; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

2.  Effect of inescapable shock on subsequent escape performance: catecholaminergic and cholinergic mediation of response initiation and maintenance.

Authors:  H Anisman; G Remington; L S Sklar
Journal:  Psychopharmacology (Berl)       Date:  1979-03-22       Impact factor: 4.530

3.  Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.

Authors:  J R Blackburn; A G Phillips
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.

Authors:  J Arnt; A V Christensen; J Hyttel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

5.  Differential reversal of various dopamine antagonists by anticholinergics in Sidman avoidance: possible relationship to adrenergic blockade.

Authors:  J M Liebman; R Neale; L Noreika; A Braunwalder
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects.

Authors:  H Anisman; M Ritch; L S Sklar
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Effects of single and long-term haloperidol administration on open field behavior of rats.

Authors:  M M Bernardi; H De Souza; J Palermo Neto
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  The effects of diphenylhydantoin on rat behavior.

Authors:  T C De Lima; J Palermo Neto
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.